Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 21, 2016; 22(23): 5430-5435
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5430
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5430
Table 1 Patients' clinical characteristics n (%)
| Lafutidine group (n = 24) | Lansoprazole group (n = 29) | P value | |
| Age (median, range) | 64 (27-80) | 56 (26-85) | 0.24 |
| Gender (male/female) | 8/16 | 22/7 | 0.0025 |
| Hiatal hernia | 13 (54) | 19 (66) | 0.57 |
| H. pylori infection | 2 (8.3) | 3 (10.3) | > 0.99 |
| Habits | |||
| Alcohol | 7 (29.2) | 13 (44.8) | 0.27 |
| Tobacco | 3 (12.5) | 6 (20.7) | 0.49 |
| Coffee | 14 (58.3) | 15 (51.7) | 0.78 |
| Co-morbidity | |||
| Hypertension | 2 (8.3) | 4 (13.8) | 0.68 |
| Diabetes mellitus | 3 (12.5) | 3 (10.3) | > 0.99 |
| Cerebrovascular disease | 0 (0) | 0 (0) | - |
| Cardiovascular disease | 0 (0) | 0 (0) | - |
| Liver disease | 1 (4.2) | 3 (10.3) | 0.62 |
| Renal failure | 0 (0) | 0 (0) | - |
| Malignancy | 2 (8.3) | 2 (6.9) | > 0.99 |
- Citation: Takenaka R, Okada H, Kawano S, Komazawa Y, Yoshinaga F, Nagata S, Inoue M, Komatsu H, Onogawa S, Kushiyama Y, Mukai S, Todo H, Okanobu H, Manabe N, Tanaka S, Haruma K, Kinoshita Y. Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease. World J Gastroenterol 2016; 22(23): 5430-5435
- URL: https://www.wjgnet.com/1007-9327/full/v22/i23/5430.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i23.5430